Medical Device Market Updates

North America Ophthalmic Devices Market Outlook to 2017

North America Ophthalmic Devices Market Outlook to 2017

Summary

GlobalData's new report, 'North America Ophthalmic Devices Market Outlook to 2017' provides key market data on the North America Ophthalmic Devices market - Canada and United States. The report provides value (USD million) data for all the market categories - Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.
- Market size and company share data for Ophthalmic Devices market categories - Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America Ophthalmic Devices market..
- Key players covered include Essilor International, Johnson & Johnson Vision Care, Inc., Alcon, Inc., Bausch & Lomb Incorporated, CIBA Vision Corporation, CooperVision, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry ... Read the full report

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Ophthalmic Devices in North America 12
3.1 Ophthalmic Devices Cross Country Comparison, Revenue ($m), 2003-2017 12
3.2 Ophthalmic Devices, North America, Overall Revenue ($m), 2003-2017 13
3.3 Ophthalmic Devices, North America, Category Volume (Units), 2003-2017 19
3.4 Ophthalmic Devices, North America, Company share (2009-2010) 24
4 Ophthalmic Devices In United States 26
4.1 Ophthalmic Devices, United States, Overall Revenue ($m), 2003-2017 26
4.2 Ophthalmic Devices, United States, Category Volume (Units), 2003-2017 32
4.3 Ophthalmic Devices, United States, Distribution Share (2009-2010) 37
4.3.1 Cataract Surgery Devices, United States, Distribution Share (2009-2010) 37
4.3.2 Glaucoma Surgery Devices, United States, Distribution Share (2009-2010) 37
4.3.3 Ophthalmic Diagnostic Equipment, United States, Distribution Share (2009-2010) 38
4.3.4 Refractive Surgery Devices, United States, Distribution Share (2009-2010) 38
4.3.5 Vision Care, United States, Distribution Share (2009-2010) 39
4.3.6 Vitreo Retinal Surgery Devices, United States, Distribution Share (2009-2010) 39
4.4 Ophthalmic Devices, United States, Company Share (2009-2010) 40
4.4.1 Ophthalmic Devices, United States, Company Share (2009-2010) 40
4.4.2 Cataract Surgery Devices, United States, Company Share (2009-2010) 42
4.4.3 Glaucoma Surgery Devices, United States, Company Share (2009-2010) 44
4.4.4 Ophthalmic Diagnostic Equipment, United States, Company Share (2009-2010) 46
4.4.5 Refractive Surgery Devices, United States, Company Share (2009-2010) 48
4.4.6 Vision Care, United States, Company Share (2009-2010) 50
4.4.7 Vitreo Retinal Surgery Devices, United States, Company Share (2009-2010) 52
5 Ophthalmic Devices In Canada 53
5.1 Ophthalmic Devices, Canada, Overall Revenue ($m) ... Read the full report

Asia-Pacific Cardiovascular Devices Market Outlook to 2017

Asia-Pacific Cardiovascular Devices Market Outlook to 2017

Summary

GlobalData's new report, 'Asia-Pacific Cardiovascular Devices Market Outlook to 2017' provides key market data on the Asia-Pacific Cardiovascular Devices market - Australia, China, India and Japan. The report provides value (USD million) data for all the market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Cardiovascular Devices market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Cardiovascular Devices market..
- Key players covered include Boston Scientific Corporation, Medtronic, Inc., ... Read the full report

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What is This Report About? 17
3 Cardiovascular Devices in Asia-Pacific 18
3.1 Cardiovascular Devices Cross Country Comparison, Revenue ($m), 2003-2017 18
3.2 Cardiovascular Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 19
3.3 Cardiovascular Devices, Asia-Pacific, Category Volume (Units), 2003-2017 27
3.4 Cardiovascular Devices, Asia-Pacific, Company share (2009-2010) 33
4 Cardiovascular Devices In Japan 35
4.1 Cardiovascular Devices, Japan, Overall Revenue ($m), 2003-2017 35
4.2 Cardiovascular Devices, Japan, Category Volume (Units), 2003-2017 41
4.3 Cardiovascular Devices, Japan, Distribution Share (2009-2010) 47
4.3.1 Cardiac Assist Devices, Japan, Distribution Share (2009-2010) 47
4.3.2 Cardiac Rhythm Management, Japan, Distribution Share (2009-2010) 47
4.3.3 Cardiovascular Monitoring and Diagnostic Devices, Japan, Distribution Share (2009-2010) 48
4.3.4 Cardiovascular Prosthetic Devices, Japan, Distribution Share (2009-2010) 48
4.3.5 Cardiovascular Surgery, Japan, Distribution Share (2009-2010) 49
4.3.6 Electrophysiology, Japan, Distribution Share (2009-2010) 49
4.3.7 External Defibrillators, Japan, Distribution Share (2009-2010) 50
4.3.8 Interventional Cardiology, Japan, Distribution Share (2009-2010) 50
4.3.9 Peripheral Vascular Devices, Japan, Distribution Share (2009-2010) 51
4.3.10 Prosthetic Heart Valves, Japan, Distribution Share (2009-2010) 51
4.4 Cardiovascular Devices, Japan, Company Share (2009-2010) 52
4.4.1 Cardiovascular Devices, Japan, Company Share (2009-2010) 52
4.4.2 Cardiac Assist Devices, Japan, Company Share (2009-2010) 54
4.4.3 Cardiac Rhythm Management, Japan, Company Share (2009-2010) 55
4.4.4 Cardiovascular Monitoring and Diagnostic Devices, Japan, Company Share (2009-2010) 56
4.4.5 Cardiovascular Prosthetic Devices, Japan, Company ... Read the full report

Europe Cardiovascular Devices Market Outlook to 2017

Europe Cardiovascular Devices Market Outlook to 2017

Summary

GlobalData's new report, 'Europe Cardiovascular Devices Market Outlook to 2017' provides key market data on the Europe Cardiovascular Devices market - France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Cardiovascular Devices market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Cardiovascular Devices market..
- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., ... Read the full report

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 16
2 Introduction 19
2.1 What is This Report About? 19
3 Cardiovascular Devices in Europe 20
3.1 Cardiovascular Devices Cross Country Comparison, Revenue ($m), 2003-2017 20
3.2 Cardiovascular Devices, Europe, Overall Revenue ($m), 2003-2017 21
3.3 Cardiovascular Devices, Europe, Category Volume (Units), 2003-2017 29
3.4 Cardiovascular Devices, Europe, Company share (2009-2010) 35
4 Cardiovascular Devices In Germany 37
4.1 Cardiovascular Devices, Germany, Overall Revenue ($m), 2003-2017 37
4.2 Cardiovascular Devices, Germany, Category Volume (Units), 2003-2017 43
4.3 Cardiovascular Devices, Germany, Distribution Share (2009-2010) 49
4.3.1 Cardiac Assist Devices, Germany, Distribution Share (2009-2010) 49
4.3.2 Cardiac Rhythm Management, Germany, Distribution Share (2009-2010) 49
4.3.3 Cardiovascular Monitoring and Diagnostic Devices, Germany, Distribution Share (2009-2010) 50
4.3.4 Cardiovascular Prosthetic Devices, Germany, Distribution Share (2009-2010) 50
4.3.5 Cardiovascular Surgery, Germany, Distribution Share (2009-2010) 51
4.3.6 Electrophysiology, Germany, Distribution Share by Revenue (2009-2010) 51
4.3.7 External Defibrillators, Germany, Distribution Share (2009-2010) 52
4.3.8 Interventional Cardiology, Germany, Distribution Share (2009-2010) 52
4.3.9 Peripheral Vascular Devices, Germany, Distribution Share (2009-2010) 53
4.3.10 Prosthetic Heart Valves, Germany, Distribution Share (2009-2010) 53
4.4 Cardiovascular Devices, Germany, Company Share (2009-2010) 54
4.4.1 Cardiovascular Devices, Germany, Company Share (2009-2010) 54
4.4.2 Cardiac Assist Devices, Germany, Company Share (2009-2010) 56
4.4.3 Cardiac Rhythm Management, Germany, Company Share (2009-2010) 58
4.4.4 Cardiovascular Monitoring and Diagnostic Devices, Germany, Company Share (2009-2010) 60
4.4.5 Cardiovascular Prostheti ... Read the full report

North America Cardiovascular Devices Market Outlook to 2017

North America Cardiovascular Devices Market Outlook to 2017

Summary

GlobalData's new report, 'North America Cardiovascular Devices Market Outlook to 2017' provides key market data on the North America Cardiovascular Devices market - Canada and United States. The report provides value (USD million) data for all the market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.
- Market size and company share data for Cardiovascular Devices market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America Cardiovascular Devices market..
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medi ... Read the full report

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 13
1.2 List of Figures 17
2 Introduction 19
2.1 What is This Report About? 19
3 Cardiovascular Devices in North America 20
3.1 Cardiovascular Devices Cross Country Comparison, Revenue ($m), 2003-2017 20
3.2 Cardiovascular Devices, North America, Overall Revenue ($m), 2003-2017 21
3.3 Cardiovascular Devices, North America, Category Volume (Units), 2003-2017 29
3.4 Cardiovascular Devices, North America, Company share (2009-2010) 35
4 Cardiovascular Devices In United States 37
4.1 Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 37
4.2 Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 43
4.3 Cardiovascular Devices, United States, Distribution Share (2009-2010) 49
4.3.1 Cardiac Assist Devices, United States, Distribution Share (2009-2010) 49
4.3.2 Cardiac Rhythm Management, United States, Distribution Share (2009-2010) 49
4.3.3 Cardiovascular Monitoring and Diagnostic Devices, United States, Distribution Share (2009-2010) 50
4.3.4 Cardiovascular Prosthetic Devices, United States, Distribution Share (2009-2010) 50
4.3.5 Cardiovascular Surgery, United States, Distribution Share (2009-2010) 51
4.3.6 Electrophysiology Distribution Share (2009-2010) 51
4.3.7 External Defibrillators, United States, Distribution Share (2009-2010) 52
4.3.8 Interventional Cardiology, United States, Distribution Share (2009-2010) 52
4.3.9 Peripheral Vascular Devices, United States, Distribution Share (2009-2010) 53
4.3.10 Prosthetic Heart Valves, United States, Distribution Share (2009-2010) 53
4.4 Cardiovascular Devices, United States, Company Share (2009-2010) 54
4.4.1 Cardiovascular Devices, United States, Company Share (2009-2010) 54
4.4.2 Cardiac Assist Devices, United States, Company Share (2009-2010) 56
4.4.3 Cardiac Rhythm Management, United States, Company Share (2009-2010) 58
4.4.4 Cardiovascul ... Read the full report

Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017

Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017

Summary

GlobalData's new report, 'Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017' provides key data, information and analysis on the global arthroscopy devices market. The report provides market landscape, competitive landscape and market trends information on the arthroscopy devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Arthroscopy Implants, Arthroscopic Shavers, Arthroscopy Fluid Management Systems, Arthroscopy Visualization Systems, Arthroscopes and Arthroscopy Radio Frequency Systems.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the arthroscopy devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Smith & Nephew, Arthrex, DePuy, KARL STORZ, Conmed Corporation, Stryker Corporation and ArthroCare Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the arthroscopy devices market globally.
- Design and develop your product ... Read the full report

1 Table of contents
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 GlobalData Report Guidance 8
3 Disease Overview - Arthritis 9
3.1 Introduction 9
3.2 Diagnosis 9
3.3 Treatment 9
3.4 Types of Arthritis 9
3.4.1 Osteoarthritis 10
3.4.2 Rheumatoid Arthritis 11
3.5 Comparison Between Osteoarthritis and Rheumatoid Arthritis 12
3.6 Juvenile Arthritis 12
4 Arthroscopy Devices Overview 13
4.1 Arthroscopes 13
4.2 Arthroscopy Fluid Management Systems 13
4.3 Arthroscopy Visualization Systems 13
4.4 Arthroscopy Implants 14
4.5 Arthroscopic Shavers 14
4.6 Arthroscopy Radio Frequency Systems 14
5 Arthroscopy Devices - Market Characterization 15
5.1 Arthroscopy Devices Market, Global, Revenue ($m), Historic, 2003-2010 15
5.2 Arthroscopy Devices Market, Global, Revenue ($m), Forecast, 2010-2017 16
5.3 Arthroscopy Devices, Market Dynamics 17
5.3.1 Arthroscopy Devices, Market Drivers 18
5.3.2 Arthroscopy Devices, Market Restraints 22
6 Global Arthroscopy Devices Market - Segment Analysis 24
6.1 Arthroscopy Implants Market, Global, Revenue ($m), Historic, 2003-2010 24
6.2 Arthroscopy Implants Market, Global, Revenue ($m), Forecast, 2010-2017 25
6.3 Arthroscopic Shavers Market, Global, Revenue ($m), Historic, 2003-2010 26
6.4 Arthroscopic Shavers Market, Global, Revenue ($m), Forecast, 2010-2017 27
6.5 Arthroscopy Fluid Management Systems Market, Global, Revenue ($m), Historic, 2003-2010 28
6.6 Arthroscopy Fluid Management Systems Market, Global, Revenue ($m), Forecast, 2010-2017 29
6.7 Arthroscopy Visualization Systems Market, Global, Revenue ($m), Historic, 2003-2010 30
6.8 Arthroscopy Visualization Systems Market, Global, Revenue ($m), Forecast, 2010-2017 31
6.9 Arthroscopes Market, Global, Revenue ($m), Historic, 2003-2010 32
6.10 Arthroscopes Market, Global, Revenue ($m), Forecast, 2010-2017 33
6.11 Arthroscopy Radio Frequen ... Read the full report

Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's new report, 'Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016' provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bone Allografts, Bone Graft Substitutes (Synthetic Bone Graft Substitutes, and bone morphogenic proteins), Bone Growth Stimulators, Demineralized Bone Matrix (DBM), and Viscosupplementation.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Genzyme Corporation, DePuy, Synthes, Smith & Nephew, and Stryker Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.
- Design and develop your product development, marketing and sales strategi ... Read the full report

1 Table of contents
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction: Orthobiologics 9
2.1 GlobalData Report Guidance 9
3 Orthobiologics: Overview 10
3.1 Applications of Orthobiologics 11
4 Orthobiologics: Global Market Characterization 12
4.1 Orthobiologics Market, Global, Revenue ($m), Historic, 2002 - 2009 12
4.2 Orthobiologics Market, Global, Revenue ($m), Forecast, 2009 - 2016 14
4.3 Orthobiologics, Market Dynamics 15
4.3.1 Orthobiologics, Market Drivers 15
4.3.2 Orthobiologics, Market Restraints 17
5 Global Orthobiologics Market: Segment Analysis 18
5.1 Bone Graft Substitutes Market, Global, Revenue ($m), Historic, 2002 - 2009 18
5.2 Bone Graft Substitutes Market, Global, Revenue ($m), Forecast, 2009 - 2016 19
5.2.1 Bone Graft Substitutes, Market Drivers 20
5.2.2 Bone Graft Substitutes, Market Restraint: Safety Concerns over Bone Morphogenetic Protein in Spinal Fusion Surgeries and High Cost is Slowing the Adoption 20
5.3 Viscosupplementation Market, Global, Revenue ($m), Historic, 2002 - 2009 21
5.4 Viscosupplementation Market, Global, Revenue ($m), Forecast, 2009 - 2016 22
5.4.1 Viscosupplementation, Market Drivers 23
5.4.2 Viscosupplementation, Market Restraint: Pricing Challenges to Continue to Plague the Viscosupplementation Market 23
5.5 Demineralized Bone Matrix Market, Global, Revenue ($m), Historic, 2002 - 2009 24
5.6 Demineralized Bone Matrix Market, Global, Revenue ($m), Forecast, 2009 - 2016 25
5.6.1 Demineralized Bone Matrix, Market Drivers 26
5.6.2 Demineralized Bone Matrix, Market Restraint: Several Potential Disadvantages such as Potential to Transmit HIV may Act as Restraint for Market Growth 26
5.7 Bone Growth Stimulators Market, Global, Revenue ($m), Historic, 2002 - 2009 27
5.8 Bone Growth Stimulators Market, Global, Revenue ($m), Forecast, 2009 - 2016 28
5.8.1 Bone Growth Stimulators, Market Driver: Increasing Numbe ... Read the full report

New report in Robotic Surgery Market

The outlook for the Robotic Surgery Equipment Manufacturing industry is mostly bright, 
with revenue projected to increase at an average annual rate of 14.9% to $4.2 billion in 
the five years to 2016. While<span class="expanded_extract off"> the industry&apos;s 
growth will start to slow down slightly as robotic systems increasingly saturate the market, 
innovation and new product introduction will likely drive rapid growth. From 2011 to 2012, 
revenue is projected to increase 21.1%.

Read Report

Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment

The reimbursement for diagnostics is the key requirement for both the diagnostic providers and the payers because while 5-7% of the hospital cost is incurred on diagnostics, they are used for around 70% of the healthcare decisions. Developing an optimum price especially with respect to emerging diagnostic technologies such as molecular diagnostics has been very challenging as evidence-based pricing does not suffice for such technologies. This complicates the scenario for early movers in diagnostics. However, there has been an on-going issue even with respect to existing technologies, as the companies have an immense need to re-consider their pricing strategies to deal with cost and demand versus reimbursement issues. Hence, it is very crucial to identify novel pricing strategies to maintain a fair plane among all the stakeholders.

Key features of this report

• Regulatory structure for U.S. and Europe
• Existing pricing strategies for healthcare diagnostic equipments
• Novel pricing strategies for healthcare diagnostic equipments
• Strategic recommendations for existing and first mover healthcare diagnostic equipments
• Indicative prices and reimbursement amounts for healthcare diagnostic equipments

Scope of this report

•Understand the existing structure for reimbursements for healthcare diagnostic equipments developed markets
• Understand the existing pricing for healthcare diagnostic equipments for developed markets
• Understand the role of various factors impacting price of the healthcare diagnostic equipments
• Understand the evolution of pricing strategies in recent times within healthcare diagnostic equipments
• Helps in determining the complete understanding of changing times within pricing with respect to reimbursements

Key Market Issues

• The healthcare diagnostic industry is currently facing the issue of lack of reimbursements for various procedures wh ... Read the full report

Table of Contents
Pricing and reimbursement strategies for diagnostics
Executive Summary 10
Market overview 10
Key findings 11
Analyzing best-fit strategies for novel pricing and reimbursement 13
Strategic recommendations 14
Chapter 1 Introduction 16
Summary 16
Key take aways 16
Report description 16
Stakeholders 17
Chapter 2 Market overview 20
Summary 20
US regulations for medical devices & diagnostics 21
United States Department of Health and Human Services (HHS) 22
United States Public Health Services (PHS) 22
National Institutes of Health (NIH) 22
Agency for Healthcare Research and Quality 22
Indian Health Services 22
Substance Abuse and Mental Health Administration 23
Centre for Disease Control and Prevention 23
Food and Drug Administration 23
US reimbursement structure 28
US reimbursement payors 29
Public health insurance 29
Medicare 29
Medicaid 29
Other public systems 30
Private health insurance 30
Employer-sponsored insurance 30
Administration 31
Financing 31
Private non-group (individual market) 31
Overview 31
Administration 31
Financing 31
US reimbursement procedures 32
Benefit eligibility 32
Billing process 34
Coding systems 34
Pricing processes 35
Guidelines for coverage decision-making 36
US diagnostic imaging reimbursement structure 37
Medicare perspective 37
European healthcare reimbursement structure 38
European healthcare regulatory structure 38
German healthcare system 40
Impact of regulations on pricing and reimbursement 43
French healthcare system 44
Impact of regulations on pricing and reimbursement 48
UK healthcare system 49
Impact of regulations on pricing and reimbursement 52
Italian healthcare system 53
Impact of regulations on pricing and reimbursement 55
Spanish healthcare system 55
Impact of regulations on pricing and reimbursement 58
European diagnostic im ... Read the full report

Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016

Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016

Summary

GlobalData's medical equipment report, 'Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016' provides key market data on the Taiwan anesthesia and respiratory devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for anesthesia and respiratory devices market categories - anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the six market categories.
- Global corporate-level profiles of key companies operating within the Taiwan anesthesia and respiratory devices market.
- Key players covered include Draegerwerk, Covidien, GE Healthcare, Philips Respironics, ResMed, and CareFusion.

Reasons to buy

- Develop business strategies by identifyin ... Read the full report

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About? 14
3 Anesthesia and Respiratory Devices In Taiwan 15
3.1 Anesthesia and Respiratory Devices, Market Segmentation 15
3.2 Anesthesia and Respiratory Devices, Taiwan, Overall Revenue ($m), 2002-2016 16
3.3 Anesthesia and Respiratory Devices Market, Taiwan, Revenue Mix ($m), 2009 18
3.4 Anesthesia and Respiratory Devices Market, Taiwan, Category Contribution (%), 2009 19
3.5 Anesthesia and Respiratory Devices, Taiwan, Category Volume (Units), 2002-2016 25
3.6 Anesthesia and Respiratory Devices, Taiwan, Company Share (2008-2009) 30
4 Anesthesia Disposables In Taiwan 31
4.1 Anesthesia Disposables, Market Segmentation 31
4.2 Anesthesia Disposables Market, Taiwan, Revenue Mix ($m), 2009 32
4.3 Anesthesia Disposables Market, Taiwan, Category Contribution (%), 2009 33
4.4 Anesthesia Disposables Overall Revenue (2002-2016) 34
4.4.1 Anesthesia Circuits Revenue (2002-2016) 37
4.4.2 Anesthesia Airway Management Revenue (2002-2016) 39
4.5 Anesthesia Disposables Overall Volume (2002-2016) 41
4.5.1 Anesthesia Circuits Volume (2002-2016) 43
4.5.2 Anesthesia Airway Management Volume (2002-2016) 45
4.6 Anesthesia Disposables Average Price (2002-2016) 47
4.7 Anesthesia Disposables Distribution Share (2008-2009) 48
4.8 Anesthesia Disposables, Taiwan, Company Share (2008-2009) 49
5 Anesthesia Machines In Taiwan 50
5.1 Anesthesia Machines, Market Segmentation 50
5.2 Anesthesia Machines Market, Taiwan, Revenue Mix ($m), 2009 51
5.3 Anesthesia Machines Market, Taiwan, Category Contribution (%), 2009 52
5.4 Anesthesia Machines Overall Revenue (2002-2016) 53
5.5 Anesthesia Machines Overall Volume (2002-2016) 56
5.6 Anesthesia Machines Average Price (2002-2016) 58
5.7 Anesthesia Machines Distribution Share (2008-2009) 59
5.8 Anesthesia Machines, Taiwan, Company Share (2008-2009) 60< ... Read the full report

Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016

Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016

Summary

GlobalData's medical equipment report, 'Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016' provides key market data on the Korea anesthesia and respiratory devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for anesthesia and respiratory devices market categories - anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the six market categories.
- Global corporate-level profiles of key companies operating within the Korea anesthesia and respiratory devices market.
- Key players covered include Draegerwerk, Covidien, GE Healthcare, Philips Respironics, ResMed, and CareFusion.

Reasons to buy

- Develop business stra ... Read the full report

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About? 14
3 Anesthesia and Respiratory Devices In Republic of Korea 15
3.1 Anesthesia and Respiratory Devices, Market Segmentation 15
3.2 Anesthesia and Respiratory Devices, Republic of Korea, Overall Revenue ($m), 2002-2016 16
3.3 Anesthesia and Respiratory Devices Market, Republic of Korea, Revenue Mix ($m), 2009 18
3.4 Anesthesia and Respiratory Devices Market, Republic of Korea, Category Contribution (%), 2009 19
3.5 Anesthesia and Respiratory Devices, Republic of Korea, Category Volume (Units), 2002-2016 25
3.6 Anesthesia and Respiratory Devices, Republic of Korea, Company Share (2008-2009) 30
4 Anesthesia Disposables In Republic of Korea 32
4.1 Anesthesia Disposables, Market Segmentation 32
4.2 Anesthesia Disposables Market, Republic of Korea, Revenue Mix ($m), 2009 33
4.3 Anesthesia Disposables Market, Republic of Korea, Category Contribution (%), 2009 34
4.4 Anesthesia Disposables Overall Revenue (2002-2016) 35
4.4.1 Anesthesia Circuits Revenue (2002-2016) 37
4.4.2 Anesthesia Airway Management Revenue (2002-2016) 39
4.5 Anesthesia Disposables Overall Volume (2002-2016) 41
4.5.1 Anesthesia Circuits Volume (2002-2016) 43
4.5.2 Anesthesia Airway Management Volume (2002-2016) 45
4.6 Anesthesia Disposables Average Price (2002-2016) 47
4.7 Anesthesia Disposables Distribution Share (2008-2009) 48
4.8 Anesthesia Disposables, Republic of Korea, Company Share (2008-2009) 49
5 Anesthesia Machines In Republic of Korea 50
5.1 Anesthesia Machines, Market Segmentation 50
5.2 Anesthesia Machines Market, Republic of Korea, Revenue Mix ($m), 2009 51
5.3 Anesthesia Machines Market, Republic of Korea, Category Contribution (%), 2009 52
5.4 Anesthesia Machines Overall Revenue (2002-2016) 53
5.5 Anesthesia Machines Overall Volume (2002-2016) 55
5.6 Anesthesia Machines Average Pric ... Read the full report